Date: 11-22-2009

Case Style: Donna Kendall v. Wyeth Pharmaceuticals, Inc., et al.

Case Number: 040600965

Judge: Sandra M. Moss

Court: Court of Common Pleas, Philadelphia County, Pennsylvania

Plaintiff's Attorney: Tobias Millrood and T. Matthew Leckman, Law Offices of Pogust, Braslow & Melrod, L.L.C., Conshohocken, Pennsylvania; Kenneth Fromston, Newburgh, New York; Brian D. Ketterer, Janet, Jenner & Suggs, Baltimore, Maryland

Defendant's Attorney: Barbara R. Binis, Amy M. Vanni, Adam M. Masin and Jobina Jones-McConnell, Ira Lefton, Michael W. King, and Christin Bassett, Reed Smith, L.L.P., Philadelphia, Pennsylvania

Kelley A. Grady, Jim Pagliaro, Emily J. Lawrence, Alicia M. Friend, Gonzalez Calvet, and Clarence H. Brown, Morgan, Lewis & Bockus, L.L.P., Philadelphia, Pennsylvania

Gita F. Rothchild, McCarter & English, L.L.P., Newark, New Jersey

Marshall P. Richer, Gail Schlanger, and Ronald Rosenkranz, Finkelstein & Partners, LLP, Newburgh, New York pro hac vice

Charles P. Goodell, Jr., Goodell, Devries, Leech & Dann, L.L.P., Baltimore, Maryland pro hac vice

Pamela Yates, Jay Mayesh, Adrienne D. Gonzalez, and William Hoffman, Kaye Scholer, L.L.P., Los Angeles, California pro hac vice

Jane Bockus, Clark, Thomas & Winters, San Antonio, Texas pro hac vice

Nat Hoffman, Winston & Strawn, L.L.P., Chicago, Illinois

Description: Donna Kendall sued Pfizer, which purchased Wyeth, on a products liability theory claiming Wyeth’s Prempro and Pharmacia & Upjohn’s Provera menopause drugs was a substantial contributing factor in causing her to develop breast cancer. Kendall, 66, had a double mastectomy in 2002 after taking the hormone-replacement drugs for 11 years.

The defenses asserted by Wyeth are not available.

Outcome: Plaintiff's verdict for $6.3 million in compensatory damages and $28 million in punitive damages.

Plaintiff's Experts:

Defendant's Experts:

Comments: